- 询价
- Elucigen
- 中国
- PBU0320
- 2025年07月11日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Recommended Refrigeration Conditions (2℃-8℃) for storage
- 英文名：
1-(6-amino-3-pyridyl)piperidine-4-carbonitrile
- 供应商：
南京鼎石
- CAS号：
1800573-45-8
- 规格：
10g///25g///50g///100g///250g///500g///1kg///5kg///17375kg
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Characterization of Wild‐Type Excitatory Amino Acid Ion Channel Receptors
3 H‐labeled radioligand (NEN Life Sciences): e.g., [3 H]D‐(−)‐3‐(2‐carboxy‐piperazine‐ 4‐yl)propyl‐1‐phosphonic acid ([3 H]CPP); [3 H]‐(±)‐cis ‐4‐phosphono‐methyl‐2‐piperidine carboxylic acid ([3 H]CGS 19755); or [3 H](±)‐E ‐2‐amino
Solid-Phase Synthesis of Neuropeptides by Fmoc Strategies
is used to protect the α-amino group of each residue. Those residues that have potentially reactive side chains are protected with acid-labile groups such as t-butyl. After removal of the Fmoc group with piperidine, the next protected amino
Synthesis and Probing of Membrane-bound Peptide Arrays
from their carboxyl termini using Fmoc-amino acid derivatives. After completion of the synthesis and cleavage of all side-chain protecting groups, the peptide array on the membrane is incubated with the potential interaction partners to identify their target sequences
技术资料暂无技术资料 索取技术资料
